Edward Gillen

Edward Gillen is the Chief Executive Officer and Board Director at GRIP Molecular Technologies, Inc, developing an electronic biosensor for lab-grade diagnostic results. Previously, he served as the Chief Executive Officer, President, and Board Director at Medality Medical, focusing on surgical reversal of type 2 diabetes. Prior to that, he held various leadership roles at BD in the Diabetes Care Division and Pharmaceutical Systems Division. Edward has a MBA in Marketing and Management from Penn State University and a BS in Management from William Paterson University of New Jersey.